ArticleActive
Billing and Coding: MolDX: Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) Testing
A54685
Effective: November 16, 2023
Updated: December 31, 2025
Policy Summary
Molecular testing for ARVD/C (commonly reported as CPT 81439) is a statutorily excluded service and is not covered. To obtain a formal denial on claims submit CPT 81439, append modifier GY for statutorily excluded services (use GX for a voluntary ABN), include the appropriate diagnosis and the DEX Z-code identifier in the specified claim fields.
Coverage Criteria Preview
Key requirements from the full policy
"Genetic testing for Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) is a statutorily excluded service and is not covered."
Sign up to see full coverage criteria, indications, and limitations.